Detection of Vascular Notch3 Deposits in Unfixed Frozen Skin Biopsy Sample in CADASIL

This study aimed to evaluate the utility of immunohistochemical staining of vascular Notch3 deposits in biopsied unfixed frozen skin samples from patients with suspected cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). We analyzed vascular Notch3 deposits in unfixed frozen skin biopsy samples obtained from 43 patients with suspected CADASIL by immunohistochemistry using antibodies against the extracellular domain (ECD) of Notch3. We also sequenced the NOTCH3 gene in all patients, as well as evaluated their symptoms and neuroimages. We found granular Notch3 ECD deposits in the vessel walls of unfixed frozen skin biopsy samples in 10 of the 43 suspected patients with CADASIL. All 10 cases with skin Notch3 ECD deposits also carried reported pathogenic variants in the NOTCH3 gene associated with CADASIL. NOTCH3 variants of unknown significance were found in the other four patients without vascular Notch3 ECD or granular osmiophilic material deposits in biopsied skin samples. The remaining 29 cases without vascular Notch3 ECD deposits did not have variants in the NOTCH3 gene. Immunohistochemical evaluation of vascular Notch3 ECD deposits in unfixed frozen biopsied skin samples may be useful for detecting Notch3 deposits in CADASIL.

[1]  R. van Doorn,et al.  NO TCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature , 2021, Neuropathology and applied neurobiology.

[2]  Y. Quiroz,et al.  Clinical and research applications of magnetic resonance imaging in the study of CADASIL , 2019, Neuroscience Letters.

[3]  M. Dichgans,et al.  The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant , 2018, Genetics in Medicine.

[4]  N. Hattori,et al.  Genotype–phenotype correlations of cysteine replacement in CADASIL , 2017, Neurobiology of Aging.

[5]  Takaaki Ito,et al.  Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014 , 2015, Journal of Neurology.

[6]  J. Attems,et al.  Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL. , 2013, Journal of neuropathology and experimental neurology.

[7]  M. Viitanen,et al.  Diagnosing Vascular Dementia by Skin Biopsy - Uniqueness of CADASIL , 2011 .

[8]  M. Viitanen,et al.  Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients , 2009, Brain : a journal of neurology.

[9]  M. Ferrari,et al.  Evaluation of diagnostic NOTCH3 immunostaining in CADASIL , 2003, Acta Neuropathologica.

[10]  H. Chabriat,et al.  Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis , 2001, The Lancet.

[11]  F. Chapon,et al.  The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. , 2000, The Journal of clinical investigation.

[12]  J. Weissenbach,et al.  Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients , 1997, The Lancet.

[13]  I. Awad,et al.  Sclerosing vasculopathy of the central nervous system in nonelderly demented patients. , 1991, Archives of neurology.

[14]  D. Munoz,et al.  On the diagnosis of CADASIL. , 2009, Journal of Alzheimer's disease : JAD.